Skip to content
Search
About Sakar
Key Milestones / History
Mission, Vision & Values
Management Desk
Rewards & Recognitions
Business
Facility
Exports
Research & Development
Quality
Future Plans
Corporate Social Responsibility
General Product
Oral – Liquid Syrup & Suspension
Liquid Injectable (Svp) – Vials & Ampoules
Cephalosporin – Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Oncology Product
Oral (Tablet, Capsule, Granules & Liquid)
Liquid Injection
Lyophilised Injection
Active Pharmaceutical Ingredient(Api)
CDMO Products
CRAMs
Clients
Investor Relations
Financial Reports (Quarterly & Annually)
Quarterly
Financial Results
Investor Presentation
Earning Audio Call Recording
Earning Call Transcript
Shareholding Pattern
Press Release
Earnings call Invite
Factsheet (Quarterly/Annually)
Annual
Annual Report
Subsidiary financials
Quarterty
Annually
Board of Directors
Board of Directors
Committees
Shareholder’s Information
Share Price Information From BSE & NSE
Notices and Intimations
Corporate Announcement
Shareholder’s Meet / AGM
Credit Rating
Policies
Corporate Governance
Corporate Governance Report
Appointment of Committee Members, Key Managerial Positions
Documents related to Corporate governance, Compliance
Board of Directors
Board Of Directors
Event Calendar
Investor Support
Registrar, Company Secretary and Transfer Agent Information
Grievance Redressal
Reverse Enquiry Toolkit
News & Award
Rewards & Recognitions
Careers
Contact Us
About Sakar
Key Milestones / History
Mission, Vision & Values
Management Desk
Rewards & Recognitions
Business
Facility
Exports
Research & Development
Quality
Future Plans
Corporate Social Responsibility
General Product
Oral – Liquid Syrup & Suspension
Liquid Injectable (Svp) – Vials & Ampoules
Cephalosporin – Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Oncology Product
Oral (Tablet, Capsule, Granules & Liquid)
Liquid Injection
Lyophilised Injection
Active Pharmaceutical Ingredient(Api)
CDMO Products
CRAMs
Clients
Investor Relations
Financial Reports (Quarterly & Annually)
Quarterly
Financial Results
Investor Presentation
Earning Audio Call Recording
Earning Call Transcript
Shareholding Pattern
Press Release
Earnings call Invite
Factsheet (Quarterly/Annually)
Annual
Annual Report
Subsidiary financials
Quarterty
Annually
Board of Directors
Board of Directors
Committees
Shareholder’s Information
Share Price Information From BSE & NSE
Notices and Intimations
Corporate Announcement
Shareholder’s Meet / AGM
Credit Rating
Policies
Corporate Governance
Corporate Governance Report
Appointment of Committee Members, Key Managerial Positions
Documents related to Corporate governance, Compliance
Board of Directors
Board Of Directors
Event Calendar
Investor Support
Registrar, Company Secretary and Transfer Agent Information
Grievance Redressal
Reverse Enquiry Toolkit
News & Award
Rewards & Recognitions
Careers
Contact Us
Quarter:
March 2023
Annual Compliance_Reg. 40 of SEBI (LODR) Regulations, 2015 for the period ended on March 2023
Annual Compliance_Reg. 7(3) of SEBI (LODR) Regulations, 2015 for the period ended on 31st March 2023
Certificate Under Reg. 74 (5) of the SEBI Regulations, 2018 for the Quarter Ended 31st March 2023
Annual Secretarial Compliance Report for the financial year 2022-23
Investor Grievances for the Quarter ended on 31st March 2023
Reconciliation of Share Audit Capital Report for the Quarter ended on March 2023
Results Publication 31-03-2023
